- Model estimates who benefits most from frequent COVID-19 boosters Medical Xpress
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION an CDC
- Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization University of Minnesota Twin Cities
- Updated COVID-19 Vaccination Effective Against ED/Urgent Care Encounters HealthDay
- Research: Vaccines Reduce Risk of Severe COVID-19 Complications Mirage News
Read More: Model estimates who benefits most from frequent COVID-19 boosters – Medical Xpress